$Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women$
QR Code

QR Code

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women

Irene Lambrinoudaki, Sophia Vlachou, Fotini Galapi, Dimitra Papadimitriou, K Papadias2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, GreeceAbstract: Zoledronic acid is a nitrogen-containing, third-generation bisphosphonate that has recently been approved for th...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Irene Lambrinoudaki, Sophia Vlachou, Fotini Galapi, Dimitra Papadimitriou, K Papadias
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/60bce27397b64a8289a909232d2b0ec5
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Once-yearly zoledronic acid in hip fracture prevention
par: Oddom Demontiero, et autres
Publié: (2009)

Nonpharmacological prevention of osteoporotic fractures
par: Cathy R Kessenich
Publié: (2007)

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
par: Shi C, et autres
Publié: (2018)

Role of zoledronic acid in the prevention and treatment of osteoporosis
par: Räkel A, et autres
Publié: (2011)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
par: María J Moro-Álvarez, et autres
Publié: (2008)

Dorsal and ventral thoracic 12 vertebra body height is associated with incident lumbar vertebral fracture in postmenopausal osteoporotic women
par: Bang Y, et autres
Publié: (2019)

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
par: Wang Z, et autres
Publié: (2021)

Comparison of bone tissue trace-element concentrations and mineral density in osteoporotic femoral neck fractures and osteoarthritis
par: Karaaslan F, et autres
Publié: (2014)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
par: Paula Rackoff
Publié: (2009)

The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
par: Kong M, et autres
Publié: (2020)

The osteoporotic male: Overlooked and undermanaged?
par: Bruno Madeo, et autres
Publié: (2007)

Could Teriparatide Replace Percutaneous Vertebral Augmentation for Patients with Osteoporotic Vertebral Compression Fracture to Some Extent? [Letter]
par: Zhou J, et autres
Publié: (2019)

Bone cement distribution in the vertebral body affects chances of recompression after percutaneous vertebroplasty treatment in elderly patients with osteoporotic vertebral compression fractures
par: Zhang L, et autres
Publié: (2017)

Bracing after percutaneous vertebroplasty for thoracolumbar osteoporotic vertebral compression fractures was not effective
par: Zhang J, et autres
Publié: (2019)

Risk Factors for New Vertebral Fracture After Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures
par: Zhang ZL, et autres
Publié: (2021)

Management of osteoporosis in the aging male: Focus on zoledronic acid
par: Paul K Piper Jr, et autres
Publié: (2009)

Annual incidence of osteoporotic hip fractures in Iran: a systematic review and meta-analysis
par: Kiarash Tanha, et autres
Publié: (2021)

Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links
par: Fisher A, et autres
Publié: (2013)

Plasma homocysteine level is a risk factor for osteoporotic fractures in elderly patients
par: Zhu Y, et autres
Publié: (2016)

Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool
par: Lin JS, et autres
Publié: (2016)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
par: Mederle OA, et autres
Publié: (2018)

Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: a randomized controlled trial [Corrigendum]
par: Lai CL, et autres
Publié: (2014)

Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia
par: Liang Y, et autres
Publié: (2016)

Comparison of activities of daily living after osteoporotic hip fracture surgery in patients admitted from home and from geriatric health service facilities
par: Horikawa A, et autres
Publié: (2014)

Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
par: Ciubean AD, et autres
Publié: (2018)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
par: Philip Sambrook
Publié: (2007)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
par: Oliver Bock, et autres
Publié: (2008)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
par: John Sunyecz
Publié: (2008)

Low Risk of Fracture With End-Range Movements of the Hip in People With Low Bone Mineral Density: A Narrative Review
par: Christina Ziebart MSc, et autres
Publié: (2021)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
par: Liu Z, et autres
Publié: (2020)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
par: Fujiwara S, et autres
Publié: (2014)

Effect of a semirigid thoracolumbar orthosis on gait and sagittal alignment in patients with an osteoporotic vertebral compression fracture
par: Jacobs E, et autres
Publié: (2019)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
par: Esteban Jódar-Gimeno
Publié: (2007)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
par: Jun Iwamoto, et autres
Publié: (2008)

Lower-serum P1NP/βCTX ratio and hypoalbuminemia are independently associated with osteoporotic nonvertebral fractures in older adults
par: Fisher A, et autres
Publié: (2017)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
par: Peker N, et autres
Publié: (2018)

12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women
par: Kong M, et autres
Publié: (2019)

Muscular strength measurements indicate bone mineral density loss in postmenopausal women
par: Zhou Z, et autres
Publié: (2013)

The effect of a combined oral calcium and vitamin D supplement for treating mild to moderate vitamin D deficiency in postmenopausal women
par: Terry Golombick, et autres
Publié: (2008)

Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: a randomized controlled trial
par: Lai CL, et autres
Publié: (2013)